VANCOUVER, British Columbia, May 15, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“ Treatment ”) is pleased to announce it has signed a Collaborative Agreement with Health Care Services International Inc (o/a Novus Health). (“ Novus Health ”) to explore utilization of Treatment’s proprietary Global Library of Medicine (“GLM”) to further enhance Novus Health’s Health Risk Assessment... Read More

VANCOUVER, British Columbia, May 08, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (the “ Company ” or “ Treatment ”), a healthcare tech company transforming patient care with AI-driven clinical insights is pleased to announce the appointment of Richard Atkins as Chief Operating Officer and a member of the executive team. Mr. Atkins brings to the business a successful career with over... Read More

VANCOUVER, British Columbia, May 01, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (the “ Company ” or “ Treatment ”) is excited to announce one of the leading US medical schools has agreed to a contract renewal utilizing Treatment’s Medical Education Suite (“ MES ”). Treatment is also in discussions with a number of other medical and nursing schools, both in the US and... Read More

VANCOUVER, British Columbia, April 17, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (the “ Company ” or “ Treatment ”) is excited to announce two new solutions, (1) AI Patient and (2) AI Doctor in a Pocket, to augment its Medical Education Suite (“ MES ”) designed to educate the next generation of healthcare providers. Treatment’s MES enhances the entire continuum of clinical content... Read More

VANCOUVER, British Columbia, April 10, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“ Treatment ”) is pleased to announce it has signed a Collaborative Agreement with aiXplain, Inc. (“ aiXplain ”) to enable greater access to Treatment’s proprietary Global Library of Medicine (“GLM”) by contributing to aiXplain’s ever-growing dynamic Artificial Intelligence (AI) marketplace.... Read More

VANCOUVER, British Columbia, April 08, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (the “ Company ” or “ Treatment ”) welcomes Prime Minister Justin Trudeau’s announcement on 7th April, 2024, that the federal government plans to fund $2.4 billion in its upcoming budget towards build capacity in Artificial Intelligence (AI) adoption. The federal government’s announcement indicates an... Read More

VANCOUVER, British Columbia, March 27, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (the “ Company ” or “ Treatment ”) is pleased to announce that the Company has received funding from The National Institute of Health (“ NIH ”) to develop a culturally sensitive AI approach for collecting family medical history. Treatment has partnered with Rush River Research in Minneapolis to... Read More

VANCOUVER, British Columbia, March 20, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (the “Company” or “Treatment”) is pleased to announce that it’s AI medical information support platform was used in the “Objective Structured Clinical Examination” (“ OSCE ”), a standard clinical exam of diagnostic aptitude at medical and nursing schools, passing the exam with a 92% success rate.... Read More

Vancouver, British Columbia, March 14, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (the “ Company ” or “ Treatment ”) (CSE: TRUE; OTC: TREIF; FFA: 939 ) is pleased to announce that, further to its news release dated February 16, 2024, it has closed a non-brokered private placement of 6,295,500 special warrants of the Company (each, a “ Special Warrant ”) at a price of $0.40 per Special Warrant, for aggregate gross... Read More

Bolstering the Leadership Team The Global Library of Medicine Passes Milestone of 1000+ Diseases Treatment Provides Platform to Support Healthcare in Nairobi, Kenya VANCOUVER, British Columbia, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (the “Company” or “Treatment”) is pleased to provide a general corporate update. Treatment has been working diligently to continue its... Read More

Vancouver, BC, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc . (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (the “Company” or “Treatment”) is pleased to announce the appointment of Mr. David Worner as Chief Financial Officer of the Company, effective February 5, 2024. Mr. Worner is currently the Chief Executive Officer & Founder of GrowthPath Partners, a transactional accounting & advisory firm that services companies... Read More

VANCOUVER, British Columbia – TheNewswire - October 31, 2023 – Treatment.com International Inc. (CSE:TRUE ) ( OTC:TREIF ) ( Frankfurt:939) (the “Company” or “Treatment”) is pleased to announce that the Company’s Board of Directors have approved a name change to “Treatment.com AI Inc.” The Company’s trading symbol on the Canadian Securities Exchange (“CSE”) shall remain the same. No action is required to be taken by... Read More

VANCOUVER, British Columbia – TheNewswire - October 18, 2023 – Treatment.com International Inc. (CSE:TRUE ) ( OTC:TREIF ) ( Frankfurt:939) (the “Company” or “Treatment”) is pleased to announce the appointment of Dr. Essam Hamza, MD to its Board of Directors and as Chief Executive Officer, effective October 17, 2023. Dr.Hamza will also join the Board on that date. The appointment of Dr. Hamza follows a mandate to appoint a... Read More

Treatment.com International Inc. (“Treatment” or the “Company”) (CSE: TRUE; OTC: TREIF; FFA: 939), is a global healthcare company that has developed a next-generation AI platform to help patients and caregivers around the world make better health decisions. Treatment’s landmark debut product, the Treatment Digital Health App , has been garnering five-star reviews on both the Apple App Store and the Google Play Store. Users’... Read More

Treatment.com International Inc. (“Treatment or the “Company”) (CSE: TRUE; OTC: TREIF; FFA: 939), a global healthcare company that has developed a next-generation AI platform to help patients and caregivers around the world make better health decisions, announces the proceeding of a non-brokered private placement, raising aggregate gross proceeds of up to $1,250,000 in unsecured convertible debentures (the “Private... Read More

Treatment.com International Inc. (“Treatment” or the “Company”) (CSE: TRUE; OTC: TREIF; FFA 939) is a global healthcare technology company that has developed a next-generation AI platform to help patients and caregivers around the world make better health decisions. After a successful launch on the Apple App Store, Treatment’s revolutionary symptom assessment tool, Treatment Digital Health App , is now available to millions... Read More

Treatment.com International Inc. (“Treatment” or the “Company”) (CSE: TRUE; OTC: TREIF; FFA 939) is a global healthcare technology company that has developed a next-generation AI platform to help patients and caregivers around the world make better health decisions. Today, Treatment announces the global launch of its much-anticipated Treatment Digital Health App, now available in the Apple App Store. The Treatment Digital... Read More

Treatment . com International Inc. (“Treatment” or the “Company”) (CSE: TRUE), (OTC: TREIF), a healthcare AI technology company, has entered into a research project agreement with the University of Minnesota to add more than 220 dermatologic diseases to their proprietary, responsive AI engine known as the Global Library of Medicine (GLM). The addition of these diagnoses will bring another level of accuracy and specificity to... Read More

Treatment.com International Inc. (“Treatment or the (“Company”) (CSE: TRUE • OTC: TREIF • 939.F) is a healthcare technology company with a passion for supporting consumers and health care providers globally with easy, AI-driven solutions. Today Treatment announces the first sale of its Treatment Primary Care Module, powering the next generation of AI-assisted healthcare. Using medically built artificial intelligence, the... Read More

Treatment.com International Inc. (“Treatment” or the “Company”) (CSE: TRUE; OTC: TREIF; FFA 939) is a global healthcare technology company that has developed a next-generation AI platform to help clinicians and patients around the world make better health decisions. Today, Treatment announces the beta release of its much-anticipated Treatment Digital Health App. This app is powered by Treatment’s proprietary AI engine which... Read More

Treatment.com International Inc. (“Treatment” or the “Company”) (CSE: TRUE), (OTC: TREIF), a healthcare AI technology company, has expanded the reach of its Global Library of Medicine (GLM) by adding more members based in Belgium. Treatment’s GLM is the world’s most advanced medical database, and the platform for a new category of tools in global healthcare delivery. The Global Library of Medicine’s consortium of doctors... Read More

Treatment.com International Inc. (“Treatment or the “Company”) (CSE: TRUE • OTC: TREIF • 939.F) is a healthcare technology company with a passion for supporting consumers and health care providers globally with easy, AI-driven solutions. Today, Treatment is announcing its plan to build our groundbreaking global “Medical Metaverse”. The Medical Metaverse will become Treatment’s roadmap for current and future customers.... Read More

Treatment.com International Inc. (“Treatment” or the (“Company”)) (CSE: TRUE • OTC: TREIF • 939.F) is a healthcare technology company with a passion for supporting consumers and health care providers with easy, supportive solutions. The Company’s unique, proprietary Global Library of Medicine (GLM) and AI engine will be leveraged in the development of a unique value-based rewards system. The Treatment tri-level software... Read More